EBI Buys Xstim to Enhance Bone Growth Stimulation Portfolio

EBI, a pioneer of electrobiology technology, has acquired Xstim, a Precision Medical Products Inc. division that develops next-gen bone growth stimulator solutions.

Acquiring Xstim boosts EBI’s bone growth stimulation portfolio with a modern, wearable, non-invasive spine fusion stimulation therapy that’s engineered to support comfort, ease of use, and clinical confidence. Adding Xstim’s capacitively coupled electrical stimulation to its platform of non-surgical and implantable healing solutions allows EBI to offer a broader range of options across lumbar spinal fusion, nonunion fracture, and failed joint fusion applications.

Combining EBI’s bone growth stimulation portfolio with Xstim’s technology platform positions the company to advance the next generation of bone healing innovation and expand treatment options.

EBI is a portfolio company of Avista Healthcare Partners, a middle-market healthcare private equity firm with more than two decades of experience building growth-oriented healthcare businesses.

“Our vision is clear: to be the trusted market leader in bone growth stimulation, dedicated to partnering with physicians to improve their patients’ bone healing outcomes,” said EBI CEO Kevin Kenny. “The addition of Xstim further supports our mission by introducing next generation products, strengthening our portfolio and expanding our R&D pipeline focused on today’s modern needs for both surgeons and patients.”

Ropes & Gray LLP served as legal counsel to EBI. William Blair served as exclusive financial advisor and Perkins Coie served as legal counsel to Precision Medical Products.